Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.

Blum AE, Venkitachalam S, Ravillah D, Chelluboyina AK, Kieber-Emmons AM, Ravi L, Kresak A, Chandar AK, Markowitz SD, Canto MI, Wang JS, Shaheen NJ, Guo Y, Shyr Y, Willis JE, Chak A, Varadan V, Guda K.

Gastroenterology. 2019 May;156(6):1761-1774. doi: 10.1053/j.gastro.2019.01.263. Epub 2019 Feb 12.

PMID:
30768984
2.

Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.

Yu M, Maden SK, Stachler M, Kaz AM, Ayers J, Guo Y, Carter KT, Willbanks A, Heinzerling TJ, O'Leary RM, Xu X, Bass A, Chandar AK, Chak A, Elliott R, Willis JE, Markowitz SD, Grady WM.

Gut. 2018 Jun 8. pii: gutjnl-2017-314544. doi: 10.1136/gutjnl-2017-314544. [Epub ahead of print]

PMID:
29884612
3.

Association of sporadic and familial Barrett's esophagus with breast cancer.

Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/doy007.

4.

The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.

Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG.

Gastroenterology. 2018 Jun;154(8):2068-2086.e5. doi: 10.1053/j.gastro.2018.02.022. Epub 2018 Feb 16. Review.

5.

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.

Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaao5848. doi: 10.1126/scitranslmed.aao5848.

6.

Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.

Khera R, Pandey A, Chandar AK, Murad MH, Prokop LJ, Neeland IJ, Berry JD, Camilleri M, Singh S.

Gastroenterology. 2018 Apr;154(5):1309-1319.e7. doi: 10.1053/j.gastro.2017.12.024. Epub 2018 Jan 3. Review.

7.

Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.

Chandar AK.

Int J Gen Med. 2017 Oct 31;10:385-393. doi: 10.2147/IJGM.S126581. eCollection 2017. Review.

8.

Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.

Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A.

PLoS One. 2017 Oct 26;12(10):e0184962. doi: 10.1371/journal.pone.0184962. eCollection 2017.

9.

Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.

Facciorusso A, Chandar AK, Murad MH, Prokop LJ, Muscatiello N, Kamath PS, Singh S.

Lancet Gastroenterol Hepatol. 2017 Feb;2(2):94-102. doi: 10.1016/S2468-1253(16)30157-1. Epub 2016 Dec 2. Review.

PMID:
28403995
10.

Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.

Davitkov P, Chandar AK, Hirsch A, Compan A, Silveira MG, Anthony DD, Smith S, Gideon C, Bonomo RA, Falck-Ytter Y.

PLoS One. 2016 Oct 14;11(10):e0163945. doi: 10.1371/journal.pone.0163945. eCollection 2016.

11.

RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas.

Blum AE, Venkitachalam S, Guo Y, Kieber-Emmons AM, Ravi L, Chandar AK, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Barnholtz-Sloan JS, Markowitz SD, Willis JE, Shyr Y, Chak A, Varadan V, Guda K.

Cancer Res. 2016 Oct 1;76(19):5628-5633. Epub 2016 Aug 8.

12.

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.

JAMA. 2016 Jun 14;315(22):2424-34. doi: 10.1001/jama.2016.7602. Review. Erratum in: JAMA. 2016 Sep 6;316(9):995.

13.

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis.

Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1412-1419.e3. doi: 10.1016/j.cgh.2016.05.032. Epub 2016 Jun 2.

14.

Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.

Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F.

Inflamm Bowel Dis. 2015 Nov;21(11):2708-17. doi: 10.1097/MIB.0000000000000546. Review.

15.

Association of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-Analysis.

Chandar AK, Devanna S, Lu C, Singh S, Greer K, Chak A, Iyer PG.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2241-55.e1-4; quiz e179. doi: 10.1016/j.cgh.2015.06.041. Epub 2015 Jul 15. Review.

16.

Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.

Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH.

Gastroenterology. 2015 Oct;149(4):958-70.e12. doi: 10.1053/j.gastro.2015.06.006. Epub 2015 Jun 16. Review.

PMID:
26091937
17.

Role of Obesity in the Pathogenesis and Progression of Barrett's Esophagus.

Chandar AK, Iyer PG.

Gastroenterol Clin North Am. 2015 Jun;44(2):249-64. doi: 10.1016/j.gtc.2015.03.001. Epub 2015 Apr 4. Review.

PMID:
26021193
18.

Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis.

Chandar AK, Singh S, Murad MH, Peyrin-Biroulet L, Loftus EV Jr.

Inflamm Bowel Dis. 2015 Jul;21(7):1695-708. doi: 10.1097/MIB.0000000000000373. Review.

PMID:
25856769
19.

Systematic review with meta-analysis: selective serotonin reuptake inhibitors for noncardiac chest pain.

Atluri DK, Chandar AK, Fass R, Falck-Ytter Y.

Aliment Pharmacol Ther. 2015 Jan;41(2):167-76. doi: 10.1111/apt.13015. Epub 2014 Nov 21. Review.

20.

Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans.

Chak A, Alashkar BM, Isenberg GA, Chandar AK, Greer KB, Hepner A, Pulice RD, Vemana S, Falck-Ytter Y, Faulx AL.

Gastrointest Endosc. 2014 Nov;80(5):774-82. doi: 10.1016/j.gie.2014.04.034. Epub 2014 Jun 25.

21.

What we know and what we need to know about familial gastroesophageal reflux disease and Barrett's esophagus.

Sun X, Chandar AK, Elston R, Chak A.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1664-6. doi: 10.1016/j.cgh.2014.03.008. Epub 2014 Mar 19. No abstract available.

PMID:
24657839
22.

Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.

Atluri DK, Chandar AK, Bharucha AE, Falck-Ytter Y.

Neurogastroenterol Motil. 2014 Apr;26(4):499-509. doi: 10.1111/nmo.12292. Epub 2013 Dec 18. Review.

PMID:
24351035
23.

Perspectives on visitors in the emergency department: their role and importance.

Totten VY, Bryant TK, Chandar AK, Hoch WB, Hunter SL, Patel NJ, Brenner BE.

J Emerg Med. 2014 Jan;46(1):113-9. doi: 10.1016/j.jemermed.2013.04.057. Epub 2013 Sep 17.

PMID:
24054883

Supplemental Content

Loading ...
Support Center